The Pharmacokinetics of Valproic Acid After Oral and Parenteral Administration in Healthy Volunteers
- 1 April 1982
- Vol. 23 (2) , 153-162
- https://doi.org/10.1111/j.1528-1157.1982.tb05063.x
Abstract
The pharmacoknetics of volproic acid were investigated in 6 healthy volunteers. After a single i.v. dose of 1000 mg valproic acid, the pharmocokinetic parameters were determined according to the open 2-compartment model. Bioavailability of valproic acid was performed by comparing the areas under curves (AUC) after i.v. and an equal single oral dose. The half-life of the initial phase was t1/2.alpha. = 0.64 .+-. 0.32 h, and the elimination half-life was calculated as t1/2.beta. = 11.55 .+-. 2.33 h. The distribution volume of the central compartment was Vc = 9.9 .+-. 0.78 l, the apparent volume of distribution was Vd.beta. = 18.2 .+-. 6.2 l, and the distribution voluem at steady state was Vss = 12.6 .+-. 1.2 l. The value for the average total clearance was Cltot = 51.1 .+-. 11.9 ml/min. In comparison to single dosing, the elimination half-life increased in average for 4 h after multiple dosing (P .ltoreq. 0.05). There was only a poor correlation between serum concentrations and concentration of valproic acid in saliva (r = 0.42).Keywords
This publication has 22 references indexed in Scilit:
- Valproic acid dosage and plasma protein binding and clearanceClinical Pharmacology & Therapeutics, 1980
- Steady‐state kinetics of valproic acid in epileptic patientsClinical Pharmacology & Therapeutics, 1978
- Glc Determination of Valproic Acid in PlasmaAnalytical Letters, 1978
- Pharmacokinetics and bioavailability of sodium valproateClinical Pharmacology & Therapeutics, 1977
- Disposition of valproic acid in manEuropean Journal of Clinical Pharmacology, 1977
- The Treatment of Childhood Epilepsy with Sodium ValproateDevelopmental Medicine and Child Neurology, 1975
- Concentration of Dipropylacetate in PlasmaEpilepsia, 1975
- The inhibitory effect of sodium n‐dipropyl acetate on the degradative enzymes of the GABA shuntFEBS Letters, 1975
- Sodium Valproate in Treatment of EpilepsyBMJ, 1974
- EFFECTS OF DI‐n‐PROPYLACETATE, AN ANTICONVULSIVE COMPOUND, ON GABA METABOLISM1Journal of Neurochemistry, 1969